Y-mAbs Therapeutics Inc.

11/15/2019 | Press release | Archived content

CTOS 2019: Intraperitoneal Radioimmunotherapy for Desmoplastic Round Cell Tumor: Results of a Phase I Study (c208dc)

Y-mAbs Therapeutics Inc. published this content on November 15, 2019, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 11, 2025 at 18:51 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io